{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:29:26Z","timestamp":1793856566372,"version":"4.6.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.amjms.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:50:15Z","timestamp":1786805415000},"page":"381-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heparin-induced thrombocytopenia and its impact on inpatient outcomes in inflammatory bowel disease"],"prefix":"10.1016","volume":"372","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3868-747X","authenticated-orcid":false,"given":"Ayobami","family":"Olafimihan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiamaka","family":"Nwachukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praise","family":"Fawehinmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafeez","family":"Shaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah Wafa","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9573","key":"10.1016\/j.amjms.2026.08.003_bib0001","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.amjms.2026.08.003_bib0002","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjms.2026.08.003_bib0003","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.trsl.2006.11.009","article-title":"Immune dysfunction in inflammatory bowel disease","volume":"149","author":"Neuman","year":"2007","journal-title":"Transl Res"},{"issue":"9","key":"10.1016\/j.amjms.2026.08.003_bib0004","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"9715","key":"10.1016\/j.amjms.2026.08.003_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0006","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.thromres.2009.10.012","article-title":"Increased thrombin generation in inflammatory bowel diseases","volume":"125","author":"Saibeni","year":"2010","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.amjms.2026.08.003_bib0007","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0016-5085(94)90741-2","article-title":"Platelets circulate in an activated state in inflammatory bowel disease","volume":"106","author":"Collins","year":"1994","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0008","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/s-0038-1645068","article-title":"Impaired fibrinolytic capacity in patients with inflammatory bowel disease","volume":"63","author":"Gris","year":"1990","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0009","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Harbord","year":"2016","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"issue":"2 Suppl","key":"10.1016\/j.amjms.2026.08.003_bib0011","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjms.2026.08.003_bib0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/DCR.0000000000000982","article-title":"The American society of colon and rectal surgeons clinical practice guideline for the prevention of venous thromboembolic disease in colorectal surgery","volume":"61","author":"Fleming","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"22","key":"10.1016\/j.amjms.2026.08.003_bib0013","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American society of hematology 2018 guidelines for venous thromboembolism prophylaxis: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0014","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0025-7125(05)70015-8","article-title":"Heparin-induced thrombocytopenia and paradoxical thromboembolism, and other side effects of heparin therapy","volume":"82","author":"Walenga","year":"1998","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjms.2026.08.003_bib0016","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood-2005-05-1938","article-title":"Anti\u2013platelet factor 4\/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin","volume":"106","author":"Warkentin","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.amjms.2026.08.003_bib0017","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/ehm.10.54","article-title":"Fondaparinux: does it cause HIT? can it treat HIT?","volume":"3","author":"Warkentin","year":"2010","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"10.1016\/j.amjms.2026.08.003_bib0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/SLA.0000000000005157","article-title":"Efficacy and safety of low molecular weight heparin versus unfractionated heparin for prevention of venous thromboembolism in trauma patients: a systematic review and meta-analysis","volume":"275","author":"Tran","year":"2022","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.amjms.2026.08.003_bib0019","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2005-03-0912","article-title":"The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study","volume":"106","author":"Prandoni","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2026.08.003_bib0020","unstructured":"Healthcare Cost and Utilization Project (HCUP). Accessed January 10, 2026. https:\/\/www.ahrq.gov\/data\/hcup\/index.html."},{"key":"10.1016\/j.amjms.2026.08.003_bib0021","unstructured":"HCUP Methods Series. Calculating NIS variances for data years 2012 and later. Accessed January 10, 2026. https:\/\/hcup-us.ahrq.gov\/reports\/methods\/2015_09.jsp."},{"key":"10.1016\/j.amjms.2026.08.003_bib0022","unstructured":"HCUP-US. NIS overview. Accessed January 10, 2026. https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp."},{"issue":"9","key":"10.1016\/j.amjms.2026.08.003_bib0023","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1007\/s10620-009-1074-z","article-title":"Validation of ICD-9-CM codes for inflammatory bowel disease among veterans","volume":"55","author":"Thirumurthi","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjms.2026.08.003_bib0024","unstructured":"Agency for Healthcare Research and Quality. Using appropriate price indices for expenditure comparisons. Accessed January 10, 2026. https:\/\/meps.ahrq.gov\/about_meps\/Price_Index.shtml."},{"issue":"5","key":"10.1016\/j.amjms.2026.08.003_bib0025","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/S2352-3026(18)30046-2","article-title":"Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study","volume":"5","author":"Dhakal","year":"2018","journal-title":"Lancet Haematol"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/ejh.14437","article-title":"Characteristics and clinical outcomes of multiple myeloma in adolescents and young adults","volume":"115","author":"Olafimihan","year":"2025","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.amjms.2026.08.003_bib0027","unstructured":"Healthcare Cost and Utilization Project (HCUP). NIS notes. Accessed January 10, 2026. https:\/\/hcup-us.ahrq.gov\/db\/vars\/hosp_region\/nisnote.jsp."},{"key":"10.1016\/j.amjms.2026.08.003_bib0028","unstructured":"StataCorp LLC. Stata statistical software. Accessed January 10, 2026. https:\/\/www.stata.com\/."},{"issue":"6","key":"10.1016\/j.amjms.2026.08.003_bib0029","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.surg.2018.07.013","article-title":"Heparin-induced thrombocytopenia in cardiac surgery: incidence, costs, and duration of stay","volume":"164","author":"Aguayo","year":"2018","journal-title":"Surgery"},{"issue":"14","key":"10.1016\/j.amjms.2026.08.003_bib0030","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","article-title":"Dalteparin versus unfractionated heparin in critically ill patients","volume":"364","author":"Cook","year":"2011","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1016\/j.amjms.2026.08.003_bib0031","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2002-07-2201","article-title":"The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study","volume":"101","author":"Girolami","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0032","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11239-020-02320-3","article-title":"Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series","volume":"51","author":"Lai","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjms.2026.08.003_bib0033","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S0049-3848(07)70143-3","article-title":"Cancer, thrombosis, and HIT","volume":"120","author":"Prandoni","year":"2007","journal-title":"Thromb Res"},{"issue":"15","key":"10.1016\/j.amjms.2026.08.003_bib0034","article-title":"Natural history of heparin-induced thrombocytopenia (HIT) in the cancer population","volume":"34","author":"Wong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjms.2026.08.003_bib0035","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.14309\/01.ajg.0000592696.36262.05","article-title":"Does inflammatory bowel disease predispose patients to an increased risk of heparin-induced thrombocytopenia?","volume":"114","author":"Aijazi","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjms.2026.08.003_bib0036","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14740\/jh876","article-title":"Risk factors in hospitalized patients for heparin-induced thrombocytopenia by real world database: a new role for primary Hypercoagulable states","volume":"10","author":"Kaur","year":"2021","journal-title":"J Hematol"},{"issue":"1","key":"10.1016\/j.amjms.2026.08.003_bib0037","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12891-020-3117-8","article-title":"Heparin-induced thrombocytopenia and acute colonic pseudo-obstruction after therapeutic anticoagulation in a very elderly patient with hip fracture: a case report","volume":"21","author":"Liu","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"10.1016\/j.amjms.2026.08.003_bib0038","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.jvca.2013.07.021","article-title":"Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: an analysis of the nationwide inpatient sample","volume":"28","author":"Seigerman","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"9","key":"10.1016\/j.amjms.2026.08.003_bib0039","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.amjms.2026.08.003_bib0040","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/jwh.2006.0167","article-title":"Argatroban therapy in women with heparin-induced thrombocytopenia","volume":"16","author":"Jang","year":"2007","journal-title":"J Womens Health"},{"issue":"1","key":"10.1016\/j.amjms.2026.08.003_bib0041","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjsurg.2009.01.029","article-title":"Heparin-induced thrombocytopenia in surgical patients","volume":"199","author":"Battistelli","year":"2010","journal-title":"Am J Surg"},{"issue":"Suppl 1","key":"10.1016\/j.amjms.2026.08.003_bib0042","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ijlh.13223","article-title":"Evolving concepts of pathogenesis of heparin-induced thrombocytopenia: diagnostic and therapeutic implications","volume":"42","author":"Chong","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"10.1016\/j.amjms.2026.08.003_bib0043","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.amjms.2026.08.003_bib0044","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"issue":"8 Suppl","key":"10.1016\/j.amjms.2026.08.003_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.amjmed.2005.06.005","article-title":"Heparin-induced thrombocytopenia: clinical manifestations and management strategies","volume":"118","author":"Menajovsky","year":"2005","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.amjms.2026.08.003_bib0046","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)00124-2","article-title":"Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia","volume":"106","author":"Wallis","year":"1999","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.amjms.2026.08.003_bib0047","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/bloodadvances.2023011756","article-title":"Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease","volume":"8","author":"Dawwas","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.amjms.2026.08.003_bib0048","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.crohns.2013.03.002","article-title":"Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients","volume":"7","author":"Ra","year":"2013","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10.1016\/j.amjms.2026.08.003_bib0049","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1159\/000538086","article-title":"Venous thromboembolism prophylaxis in inflammatory bowel disease inpatients: systematic review and meta-analysis","volume":"147","author":"McNeil","year":"2024","journal-title":"Acta Haematol"},{"issue":"12","key":"10.1016\/j.amjms.2026.08.003_bib0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41575-021-00492-8","article-title":"International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease","volume":"18","author":"Olivera","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2 Suppl","key":"10.1016\/j.amjms.2026.08.003_bib0051","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2026.08.003_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101745","article-title":"A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study","volume":"55","author":"Nilius","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.amjms.2026.08.003_bib0053","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3786","article-title":"Accuracy of diagnosing heparin-induced thrombocytopenia","volume":"7","author":"Larsen","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926003125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926003125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:15:09Z","timestamp":1793855709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962926003125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0002962926003125"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2026.08.003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin-induced thrombocytopenia and its impact on inpatient outcomes in inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}